Deborah Ockert

A European pharmaceutical company initiative challenging the regulatory requirement for acute toxicity studies in pharmaceutical drug development

Sally Robinson, Jean‐Luc Delongeas, Elizabeth Donald et al. · Regulatory Toxicology and Pharmacology · 2007 · 104 citations

Drug Safety, Regulatory Requirement, Medicine +10

A global pharmaceutical company initiative: An evidence-based approach to define the upper limit of body weight loss in short term toxicity studies

Kathryn Chapman, Fiona Sewell, Linda Allais et al. · Regulatory Toxicology and Pharmacology · 2013 · 70 citations · Full text

Granulomatous inflammation of the oropharyngeal cavity as a possible cause for unexpected high mortality in a Fischer 344 rat carcinogenicity study.

Paul‐Georg Germann, Deborah Ockert · PubMed · 1994 · 30 citations

Pathology, Gavaged Fischer 344, Anatomy +17

Mesenteritis precedes vasculitis in the rat mesentery after subacute administration of a phosphodiesterase type 4 inhibitor

Lars Mecklenburg, Anke Heuser, Tobias Juengling et al. · Toxicology Letters · 2005 · 29 citations

Rheumatology, Allergy, Vasculitis +8

Selective Inhibition of PDE4 in Wistar Rats Can Lead to Dilatation in Testis, Efferent Ducts, and Epididymis and Subsequent Formation of Sperm Granulomas

Anke Heuser, Lars Mecklenburg, Deborah Ockert et al. · Toxicologic Pathology · 2012 · 19 citations

Spermatogenesis, Fertility, Immunology +23